Combined Anastrozole and Antiplatelet Therapy Treatment Differentially Promotes Breast Cancer Cell Survival

Thromboembolic disorders are the second leading cause of death in breast cancer. Antiplatelet therapy combined with cancer therapy is a potential treatment strategy against cancer-associated thromboembolic disorders; however, the efficacy of such dual treatment has not been established. This study r...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Microscopy and microanalysis Ročník 26; číslo 3; s. 497 - 508
Hlavní autoři:	Xulu, Kutlwano, Duarte, Raquel, Augustine, Tanya
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New York, USA Cambridge University Press 01.06.2020 Oxford University Press
Témata:	Anastrozole Anastrozole - pharmacology Annexin A5 Apoptosis Aspirin Biological Applications Biotechnology Breast cancer Breast Neoplasms - drug therapy Cancer therapies Cell death Cell growth Cell Line, Tumor Cell survival Cell Survival - drug effects Clopidogrel Combined treatment Cytochrome Cytotoxicity Disorders Enzymes Flow cytometry Humans Iodides L-Lactate dehydrogenase Lactate dehydrogenase Lactic acid MCF-7 Cells Mortality Necrosis Penicillin Phenotypes Phosphatidylserine Plasma Platelet Aggregation Inhibitors - pharmacology Propidium Propidium iodide Pseudopodia Scanning electron microscopy Statistical analysis Survival Therapeutic applications Therapy Thromboembolism Thrombosis Toxicity Tumor cell lines Tumors South Africa breast cancer cell survival antiplatelet therapy anastrozole
ISSN:	1431-9276, 1435-8115, 1435-8115
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!